Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Ther. 2019 May 7;201:25–38. doi: 10.1016/j.pharmthera.2019.05.001

Table 4.

Time-dependent inhibition of recombinant cytochrome P450 activity by cannabinoids.

Enzyme Substrate Reaction THC CBDa CBN Reference
KI (μM) kinact (min−1) kinact/KI (min−1μM−1) KI (μM) kinact (min−1) kinact/KI (min−1μM−1) KI (μM) kinact (min−1) kinact/KI (min−1μM−1)
CYP1A1 7-Ethoxyresorufin O-deethylation 1.2 0.023 0.019 5.9 0.316 0.054 0.09 0.019 0.21 (Yamaori et al., 2010)
CYP1A2 - - - 0.59 0.109 0.19 - - -
CYP1B1 - - - 3.1 0.027 0.0087 - - -
CYP2A6 Coumarin 7-hydroxylation 0.86 0.017 .020 - - - 1.01 0.0091 0.0090 (Yamaori et al., 2011)
a

Also showed time-dependent inhibition of 7-ethoxyresorufin O-deethylation in human liver microsomes (kinact, 0.152 min−1; KI, 2.1 μM). Dashes indicate data were not available.